Health Care Use & Policy

TUESDAY, MAY 23, 8:00AM-7:00PM

Allergy	Hematological Disorders	Patient-Reported Outcomes
Asthma	Infection	Skin
Cancer	Muscular-Skeletal Disorders	Smoking
Cardiovascular Disease	Osteoporosis	Surgery
Ear	Other	Health Care Use & Policy
Eye	Pain


Health Care Use & Policy

PHP1	A COMPARISON OF CLINICAL TRIAL PARTICIPANTS TO THE GENERAL PATIENT POPULATION Bolge SC, Mills DL Consumer Health Sciences, Princeton, NJ, USA

PHP2	MEMBERS INITIAL EXPERIENCE WITH A CONSUMER-DRIVEN PHARMACY BENEFIT PLAN DESIGN Gams EL, Lee KY, Watkins SM, Harte-O'Reilly MT, Mehta AN Walgreens Health Services, Deerfield, IL, USA

PHP3	IMPACT OF CONSUMER-DIRECTED HEALTH PLAN ON PHARMACY UTILIZATION Moore J, Marks A Caremark, Scottsdale, AZ, USA

PHP4	OUT-OF-POCKET PRICE OF OUTPATIENT MEDICATIONS IN THE UNITED STATES Craig B1, Deb P2 1University of Arizona, Tucson, AZ, USA, 2Hunter College, New York, NY, USA

PHP5	WITHDRAWN

PHP6	BENEFICIARIES' OUT-OF-POCKET COSTS UNDER THE MEDICARE PRESCRIPTION DRUG BENEFIT: EVIDENCE FROM MEDICARE DISCOUNT DRUG CARD CLAIMS DATA Esposito D1, Roebuck MC2, Lewis M2 1Mathematica Policy Research, Inc, Princeton, NJ, USA, 2Caremark, Hunt Valley, MD, USA

PHP7	THE DECISION TO CONDUCT A HEAD-TO-HEAD COMPARATIVE TRIAL: A GAME-THEORETIC ANALYSIS Mansley EC1, Elbasha EH2, Teutsch SM1, Berger ML1 1Merck & Co., Inc, West Point, PA, USA, 2Merck & Co., Inc, Blue Bell, PA, USA

PHP8	BRITISH COLUMBIAN PHYSICIANS' OPINIONS REGARDING REFERENCE DRUG AND GENERIC SUBSTITUTION PROGRAMS Polinski J1, Maclure M2, Marshall B2, Cassels A2, Agnew-Blais J1, Patrick A1, Schneeweiss S3 1Brigham and Women's Hospital, Boston, MA, USA, 2University of Victoria, Victoria, BC, Canada, 3Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

PHP9	SUMMARY OF THE FIRST YEAR OF A DISEASE MANAGEMENT PROGRAM IN PATIENTS WITH BLEEDING DISORDERS Tencer T1, Shapiro A2, Roberson C2, Johnson KA1 1University of Southern California, Los Angeles, CA, USA, 2Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA

PHP10	CHARACTERISTICS OF SENIORS WITH HIGH ANNUAL PRESCRIPTION DRUG EXPENDITURES: FINDINGS FROM THE 2002 AND 2003 MEDICAL EXPENDITURE PANEL SURVEY Daniel GW, Malone DC University of Arizona, Tucson, AZ, USA

PHP11	PRESCRIPTION PATTERNS OF POTENTIALLY INAPPROPRIATE MEDICATIONS AMONG OLDER MEDICARE MANAGED CARE BENEFICIARIES Bonnet PO, Yip JY, Leung M SCAN, Long Beach, CA, USA

PHP12	MEDICINE PRICES, AVAILABILITY AND AFFORDABILITY IN RAJASTHAN, INDIA Kotwani A1, Ewen M2, Laing R3, Gurbani N4, Sharma S5, RoyChaudhury R6 1Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India, 2Health Action International Europe, Amsterdam, The Netherlands, 3WHO, Geneva, Switzerland, 4Public Health Training Institute, Jaipur, India, 5IHBAS, Delhi, India, 6INCLEN Inc, New Delhi, India

PHP13	ENHANCING THE SAFETY OF OTC MEDICATION USE FOR HISPANIC CONSUMERS WITH BILINGUAL LABELS Sansgiry S, Chanda S, Abbass I, Murty S, Shringarpure G 1University of Houston, Houston, TX

PHP14	WITHDRAWN

PHP15	THE CORRELATION OF SATISFACTION OF MEDICARE BENEFICIARIES WITH ACCESS AND QUALITY OF CARE Crea JE1, Seoane-Vazquez E2, Szeinbach SL1 1The Ohio State University, Columbus, OH, USA, 2Ohio State University, Columbus, OH, USA

PHP16	THE IMPACT OF THE PHARMACY AND THERAPEUTICS COMMITTEE ON THE PATIENTS' ACCESS TO PRESCRIPTION DRUGS IN THE SAUDI MINISTRY OF HEALTH: EXPLORATORY AND COMPARISON STUDY Alkelya MA1, Kreling DH2 1University of Wisconsin School of Pharmacy, Madison, WI, USA, 2University of Wisconsin School of Pharmacy, Madison, WI, USA

PHP17	IMPACT OF CO-PAY DIFFERENTIAL ON GENERIC PRESCRIPTIONS FILLED THROUGH 90-DAY RETAIL CHANNEL Jiang JZ, Fuldeore M, Sun SX, Lee KY Walgreens Health Services, Deerfield, IL, USA

PHP18	IMPACT OF STEPS (SAFE, THERAPEUTIC AND ECONOMIC PHARMACEUTICAL SELECTION) MODEL ON PRESCRIBING COSTS OF STATINS Alabbadi I1, Crealey G2, Troughton T3, Baird S4, Miars J5, Scott M3, McElnay J1 1Queen's University Belfast, Belfast, Northern Ireland, UK, 2Clinical Research Support Centre & Queen's university Belfast, Belfast, Northern Ireland, UK, 3Antrim Area Hospital, Antrim, Northern Ireland, UK, 4Broughshane Medical Practice, Antrim, Northern Ireland, UK, 5United Hospitals Trust, Antrim, Northern Ireland, UK

PHP19	COST SAVINGS ASSOCIATED WITH TABLET SPLITTING PROGRAM IN A PHARMACY BENEFIT MANAGEMENT SETTING Gomes JP, Sun SX, Bertram CT Walgreens Health Services, Deerfield, IL, USA

PHP20	ISPOR CONTRIBUTED RESEARCH 1998-2005: EVALUATION OF TRENDS & QUALITY INDICATORS Smith MD1, McGhan W2 1International Society for Pharmacoeconomics and Outcomes Research, Lawrenceville, NJ, USA, 2University of the Sciences, Philadelphia, PA, USA

PHP21	CALCULATION OF LORENZ CONCENTRATION CURVES AND GINI COEFFICIENT OF HEALTH EXPENDITURES IN HUNGARY Boncz I1, S�ntha K1, Szaszk� D1, D�zsa C2, Sebesty�n A3 1National Health Insurance Fund Administration (OEP), Budapest, Hungary, 2Ministry of Health, Budapest, Hungary, 3National Health Insurance Fund Administration (OEP), P�cs, Hungary

PHP22	PRESCRIPTION DRUG PRICE COMPARISONS BETWEEN CANADIAN AND US ON-LINE PHARMACIES OVER A SIX-MONTH PERIOD Richards KM, Shepherd MD 1University of Texas, Austin, TX, USA

PHP23	EFFECT OF INSURANCE TYPE ON HEALTH PLANS' SPENDING ON SPECIALTY PHARMACEUTICALS: AN EMPIRICAL ANALYSIS Chen CC1, Mullins CD1, DeVries AR2 1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2Highmark, Inc, Pittsburgh, PA, USA

PHP24	ELECTRONIC INTERFACES FOR SHARING PATIENT DATA: ESTIMATING RETURN ON INVESTMENT IN HOSPICE Mondgock D1, Reifsnyder J2, Magee H2 1ExcelleRx, Inc, Philadelphia, PA, USA, 2excelleRx, Inc, Philadelphia, PA, USA

PHP25	HEALTH-RELATED QUALITY OF LIFE ASSESSMENT IN PHARMACEUTICAL CARE: EVALUATING PHARMACIST'S KNOWLEDGE, UNDERSTANDING AND PERCEIVED BARRIERS IN PHARMACY PRACTICE Chandak P1, Wu WK2, Pantaleo N3 1St. John's University, Queens, NY, USA, 2St. John's Univesity, Queens, NY, USA, 3Jamaica Hospital Medical Center, Jamaica, NY, USA

PHP26	DEVELOPING A MEASURE OF PATIENT EMPOWERMENT TO BE APPLIED IN THE GENERAL COMMUNITY Loukanova S, Bridges JFP University of Heidelberg, Heidelberg, Germany

PHP27	CLUSTER ANALYSIS OF STATE MEDICAID PROGRAMS Roy S, Madhavan SS West Virginia University, Morgantown, WV, USA

PHP28	THE EFFECT OF HIGH-RISK MEDICATIONS ON VISIT TIME WITH PHYSICIANS: RESULTS FROM THE NAMCS SURVEY John EJ1, Farris K1, Brooks JM2 1University of Iowa, Iowa City, IA, USA, 2USRDS Economic Special Study Center, The University of Iowa, Iowa City, IA, USA

PHP29	Withdrawn

Contributed Posters Session I